115
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      Evaluation of antiviral activity of fractionated extracts of sage Salvia officinalis L. (Lamiaceae)

      Read this article at

      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          In the present study, we examined cytotoxicity and extracellular and intracellular antiviral activity of frac?tionated extracts of wild and cultivated sage Salvia officinalis L. (Lamiaceae) in vitro using the WISH-VSV model system. Extracts were obtained by fractionating depigmented ethanol extracts of sage plants with supercritical CO2 at different pressures. Cytotoxicity was determined by examining cellular morphology in situ with the aid of a colorimetric micromethod and by cell staining with trypan blue. The fraction of distilled cultivated sage obtained at CO2 pressure of 300 bars and temperature of 60?C (149/3) was the most cytotoxic, with CTD10 44 ?g/ml. That of non-distilled cultivated sage obtained at CO2 pressure of 500 bars and temperature of 100?C (144/5) was the least toxic (CTD10 199 ?g/ml). Moreover, 144/5 had an antiviral effect at the intracellular level: when added 5 hours before VSV infection, it caused 100% reduction of CPE at concentrations of 99.5 and 199.0 ?g/ml; when added after virus penetration had occurred, the same concentrations caused 35 and 60% reduction, respectively. The obtained results indicate that antiviral activity of 144/5 involves inhibition of the early steps of the virus infective cycle without a direct virucidal effect. Abbreviations: WISH - human amnion epithelial cells, VSV - vesicular stomatitis virus, HSV - herpes simplex virus, CPE - cytopathic effect, IS - selectivity index, TCID50 - tissue culture infective dose, CTD10 - 10% cytotoxic concentrations.

          Abstract

          U radu je ispitivana antiviralna aktivnost razlicito frakcionisanih ekstrakata divlje i gajene zalfije Salvia officinalis L. (Lamiaceae) u in vitro uslovima koristeci WISH-VSV model sistem. Ekstrakti su dobijeni frakcionisanjem depigmentisanog etanolnog biljnog ekstrakta pod razlicitim pritiskom CO2. Citotoksicnost je odredjivana pracenjem celijske morfologije in situ, i bojenjem celija sa tripan plavim. Frakcija gajene zalfije dobijena na CO2 pritisku od 300 bara i temperaturi od 60?C (149/3) je pokazala najvecu citotoksicnost (CTD10 44 ?g/ml). Frakcija nedestilisane gajene zalfije dobijena na CO2 pritisku od 500 bara i temperaturi od 100?C (144/5) je pokazala najmanju toksicnost (CTD10 199 ?g/ml). Takodje, frakcija 144/5 je pokazala i antiviralni efekat na intracelularnom nivou: kada se celije tretiraju 5 sati pre VSV infekcije, redukcija CPE je bila 100% na koncentraciji od 99.5 i 199.0 ?g/ml; kada se celije tretiraju posle ulaska virusa u celiju na istim koncentarcijama redukcija CPE iz?nosi 35% odnosno 60%. Dobijeni rezultati ukazuju da frakcija 144/5 ima antiviralnu aktivnost koja se ostvaruje krozinhibiciju ranih stupnjeva viralne infekcije bezdirektnog virucidalnog efekta.

          Related collections

          Most cited references19

          • Record: found
          • Abstract: not found
          • Article: not found

          Interferons and their actions.

            Bookmark
            • Record: found
            • Abstract: found
            • Article: not found

            Extracts and molecules from medicinal plants against herpes simplex viruses.

            Herpes simplex viruses (HSV-1 and -2) are important pathogens for humans, especially in the case of highly susceptible adults. Moreover, HSV-2 has been reported to be a high risk factor for HIV infection. Therefore, the discovery of novel anti-HSV drugs deserves great efforts. In this paper, we review anti-HSV substances from natural sources, including both extracts and pure compounds from herbal medicines, reported in studies from several laboratories. The role of traditional medicine for the development of anti-HSV compounds is also discussed. Interestingly, it was found that traditional medicines, like Ayurvedic, traditional Chinese (TCM), Chakma medicines, are good and potential sources for promising anti-HSV drugs. A second objective of this review is to discuss several anti-HSV compounds with respect to their structure-activity relationship (SAR). A large number of small molecules, like phenolics, polyphenols, terpenes (e.g., mono-, di-, tri-), flavonoids, sugar-containing compounds, were found to be promising anti-herpetic agents. Our major conclusion is that natural products from medicinal plant extracts are very important source of anti-HSV agents.
              Bookmark
              • Record: found
              • Abstract: found
              • Article: not found

              Salvia officinalis extract in the treatment of patients with mild to moderate Alzheimer's disease: a double blind, randomized and placebo-controlled trial.

              Alzheimer's disease is characterized by a slow, progressive decline in cognitive function and behaviour. Acetylcholine esterase inhibitors are the only agents approved by the Food and Drug Administration for the treatment of Alzheimer's disease. All other agents prescribed for the treatment of Alzheimer's disease are used on an off-label basis. Current research into new drugs is focused on agents that will prevent, slow down and/or halt the progress of the disease process. Salvia officinalis has been used in herbal medicine for many centuries. It has been suggested, on the basis of traditional medicine, its in vitro cholinergic binding properties and modulation of mood and cognitive performance in humans, that Salvia officinalis might potentially provide a novel natural treatment for Alzheimer's disease. The objective of this study was to assess the efficacy and safety of Salvia officinalis extract using a fixed dose (60 drops/day), in patients with mild to moderate Alzheimer's disease, over a 4-month period. This was a 4-month, parallel group, placebo-controlled trial undertaken in three centres in Tehran, Iran. Patients with mild to moderate Alzheimer's disease aged between 65 and 80 years (n = 42, 18 women) with a score of > or = 12 on the cognitive subscale of Alzheimer's Disease Assessment Scale (ADAS-cog) and < or = 2 on the Clinical Dementia Rating (CDR) were randomized to placebo or fixed dose of S. officinalis extract. Over the 16 weeks, the main efficacy measures were the change in the ADAS-cog and CDR-Sum of Boxes scores compared with baseline. In addition, side-effects were systematically recorded throughout the study using a checklist. At 4 months, S. officinalis extract produced a significant better outcome on cognitive functions than placebo (ADAS-cog: F = 4.77, d.f. = 1, P = 0.03) (CDR-SB: F = 10.84, d.f. = 1, P < 0.003). There were no significant differences in the two groups in terms of observed side-effects except agitation that appears to be more frequent in the placebo group (P = 0.09). The results of this study indicate the efficacy of S. officinalis extract in the management of mild to moderate Alzheimer's disease. Moreover, S. officinalis may well reduce agitation of patients but this needs to be confirmed.
                Bookmark

                Author and article information

                Contributors
                (View ORCID Profile)
                (View ORCID Profile)
                Journal
                Archives of Biological Sciences
                Arch biol sci (Beogr)
                ARCH BIOL SCI
                ARCH BIOL SCI BELGRA
                ARH BIOL NAUKA
                ARH BIOL NAUKA BEOGR
                ARHIV BIOL NAUKA
                National Library of Serbia
                0354-4664
                1821-4339
                2008
                2008
                : 60
                : 3
                : 421-429
                Affiliations
                [1 ]Institut za imunologiju i virusologiju 'Torlak', Beograd
                [2 ]Katedra za mikrobiologiju, Biološki fakultet, Beograd
                Article
                10.2298/ABS0803421S
                34e09fc0-0003-4547-b1be-2394fbd45d75
                © 2008

                http://creativecommons.org/licenses/by-nc-nd/4.0/

                History

                Comments

                Comment on this article